US FDA Considering New Requirements for Off-Label Use Data
FDA has published updated draft guidance addressing distribution of scientific and marketing materials related to unapproved uses of medical devices, drugs and other products under Food and Drug Administration oversight. The agency was accepting public comments on the guidance through April 2014.